Related Experiment Video

Updated: Apr 20, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

1.5K

Passive immunization through polyclonal antibodies against IsdE showed protective activity in an experimental

Behnaz Rashidieh1, Setareh Haghighat2

  • 1Department of Microbiology, TeMS.C., Islamic Azad University, Tehran, Iran.

Folia Microbiologica
|April 18, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Staphylococcus aureusIron uptake systemsIsdE ProteinPassive immunizationPrevention

More Related Videos

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
09:15

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection

Published on: February 28, 2019

13.8K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.5K

Related Experiment Videos

Last Updated: Apr 20, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

1.5K
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
09:15

A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection

Published on: February 28, 2019

13.8K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.5K

Related Concept Videos

Active versus Passive Immunity01:31

Active versus Passive Immunity

12.3K
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
12.3K
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

110
Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
110

Articles linked to this work by shared authors, journal, and citation graph.

Next-generation vaccine adjuvants: Integrating nanotechnology, systems immunology, and computational approaches for precision vaccinology.

Human vaccines & immunotherapeutics·2026

Comparison of Immunogenicity of Cood-Cotd, CfaB-st-CfaE, and Cssa-Cssb-ltb Chimeric Proteins and Their Chitosan Nanoparticles Against ETEC in an Animal Model.

The protein journal·2026

Protective efficacy of a PcrV-based vaccine formulated with chitosan nanoparticles against Pseudomonas aeruginosa infection in burn and sepsis mouse models.

Burns : journal of the International Society for Burn Injuries·2026

Progress and application of biopolymer-based packaging systems integrated with Zataria multiflora Boiss. (Shirazi thyme) essential oil.

Food chemistry: X·2026

Evaluating the Efficacy of a Semi-Solid Formulation with Clove Oil and Curcumin versus Clindamycin in the Treatment of Acne Vulgaris: A Comprehensive Study of Preclinical and Clinical Findings.

Advanced pharmaceutical bulletin·2025

Next-generation antiviral peptides: AI-driven design, translational delivery platforms, and future therapeutic directions.

Virus research·2025

Methodological heterogeneity in mushroom extract antimicrobial research (2012-2025): a structured narrative evidence gap analysis and proposed reporting framework.

Folia microbiologica·2026

Extracellular silver nanoparticles by Citricoccus alkalitolerans and Brevibacillus brevis using response surface methodology: characterization, antibacterial activity, and biocompatibility assessment on nonwoven fabric for wound dressing applications.

Folia microbiologica·2026

Ignatzschineria indica bacteremia in a fatal case of accidental wound myiasis.

Folia microbiologica·2026

Bacteriophages and polymeric delivery systems: a mapping review.

Folia microbiologica·2026

Synergistic pre‑treatment-driven dark fermentation of domestic organic waste for high‑yield biohydrogen production.

Folia microbiologica·2026

Phylogenetic characterization and optimization of waste-valorizing Priestia megaterium GASCKPHA2 for sustainable polyhydroxyalkanoate production.

Folia microbiologica·2026

Early Growth Response 1-Associated Epithelial Autophagy-Related Changes in Allergic Airway Inflammation.

Pediatric discovery·2026

Galectin-3 restrains T cell-driven inflammation in the testis and epididymis.

Cell death & disease·2026

Dynamics of Anti-ABO(H) Antibody Expression in SARS-CoV-2-Infected Patients.

ACS chemical biology·2026

γδ T cell knockout chickens as a model to investigate the T cell response against Infectious Bursal Disease infection.

Veterinary immunology and immunopathology·2026

One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.

Vaccine·2026

Higher Pediatric Influenza Vaccination Coverage in Pooled Northern Hemisphere Countries with Public Access to Live Attenuated Influenza Vaccine: Implications for Immunization Policy.

Infectious diseases and therapy·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us